GSK melanoma drug combination wins accelerated U.S. approval

LONDON, Jan 9 (Reuters) - A combination treatment from GlaxoSmithKline for melanoma, the deadliest form of skin cancer, has won accelerated approval from U.S. regulators.

Read more here >> Reuters | Free WordPress set up